1. The effects of dapagliflozin on urinary metabolites in patients with type 2 diabetes

   Mulder, S., Heerspink, H. J. L., Darshi, M., Kim, J. J., Laverman, G. D., Sharma, K. & Pena, M. J., 2-Jul-2019, In : Diabetes obesity & metabolism.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

   Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A. & Mayer, G., Jul-2019, In : Diabetologia. 62, 7, p. 1154-1166 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Valuing Health Status in the First Year of Life: The Infant Health-Related Quality of Life Instrument

   Jabrayilov, R., Vermeulen, K. M., Detzel, P., Dainelli, L., van Asselt, A. D. I. & Krabbe, P. F. M., Jun-2019, In : Value in Health. 22, 6, p. 721-727 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

   Pollock, C., Stefansson, B., Reyner, D., Rossing, P., Sjostrom, C. D., Wheeler, D. C., Langkilde, A. M. & Heerspink, H. J. L., Jun-2019, In : Lancet Diabetes & Endocrinology. 7, 6, p. 429-441 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Evaluation of the psychometric properties of the endoscopic endonasal sinus and skull base surgery questionnaire (EES-Q) in a prospective cohort study

   Ten Dam, E., Korsten-Meijer, A. G. W., Hoving, E. W., Kuijlen, J. M., van der Laan, B. F. A. M., Feijen, R. A. & Krabbe, P. F. M., Jul-2019, In : Clinical Otolaryngology. 44, 4, p. 565-571 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (2,013) »

1. GIANTT Groningen Initiative to ANalyse Type 2 diabetes Treatment

   Denig, P. (Creator), Universitair Medisch Centrum Groningen / Rijksuniversiteit Groningen, 1-Jan-2007

   http://www.giantt.nl and one more link, http://www.giantt.nl/enoutline.htm (show fewer)

   Dataset

View all (1) »

1. SHARE PhD Top Publication Award

   Ahmed Shahabeddin Parizi (Recipient), Paul Krabbe (Recipient) & Karin Vermeulen (Recipient), 10-Nov-2017

   Prize › Academic

2. Member Executive Research Committee

   Paul Krabbe (Recipient), 1-Aug-2013

   Prize: Election to learned society › Academic

3. Best abstract award European Respiratory Society contress

   Eelko Hak (Recipient), 24-Oct-2014

   Prize › Academic

View all (8) »

1. 5th CBG-MEB Regulatory Science Day

   Petra Denig (Keynote speaker)

   3-Feb-2017

   Activity: Talk or presentation › Professional

2. Inside oud

   Petra Denig (Keynote speaker)

   30-Sep-2014

   Activity: Talk or presentation › Professional

3. ZonMw, Netherlands Org Hlth Res & Dev (External organisation)

   Petra Denig (Member)

   27-Mar-2016 → 11-Apr-2016

   Activity: Membership › Membership of committee › Academic

View all (34) »

1. Hoe een veilig vaccin tegen Lyme het slachtoffer werd van slechte pr

   Maarten Postma

   22/04/2017

   1 item of media coverage

   Press/Media: Expert Comment › Popular

2. Verschillen in bijwerkingen bij man en vrouw onder de loep

   Petra Denig

   14/04/2017

   1 item of media coverage

   Press/Media: Research › Popular

3. ZonMw K&D Agenda Diabetes

   Petra Denig

   11/11/2016

   1 item of media coverage

   Press/Media: Public Engagement Activities › Popular

View all (13) »